{"entity":{"type":"insider","cik":"0001389177","url":"/insider/0001389177","json_url":"/insider/0001389177.json","name":"O'Connor Rita M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":6,"first":"2007-07-25","last":"2022-03-16","span_basis":"filed_date"},"name_variants":[{"name":"O'Connor Rita M","source":"filing","n_filings":6,"first_seen":"2007-07-25","last_seen":"2022-03-16"}],"transactions":[{"id":6566450,"accession":"0000921895-22-000884","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-22-000884","line_url":"/filing/0000921895-22-000884","is_derivative":false,"issuer_cik":"0001389177","issuer_name":"PLx Pharma Inc.","issuer_ticker":"PLXP","issuer_name_source":null,"issuer_url":"/issuer/0001389177","owner_cik":"0001389177","owner_name":"O'Connor Rita M","owner_display_name":"O'Connor Rita M","owner_url":"/insider/0001389177","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13700.0,"shares_display":"13,700","price_per_share":3.658541605839416,"price_display":"3.66","price_state":"stated","total_value":50122.02,"total_display":"50,122.02","total_whole":"50,122","shares_owned_after":22970.0,"shares_owned_after_display":"22,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-16","scope":"insider","n_lines":2},{"id":2708908,"accession":"0001193805-20-001112","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-20-001112","line_url":"/filing/0001193805-20-001112#line-2","is_derivative":false,"issuer_cik":"0001389177","issuer_name":"PLx Pharma Inc.","issuer_ticker":"PLXP","issuer_name_source":null,"issuer_url":"/issuer/0001389177","owner_cik":"0001389177","owner_name":"O'Connor Rita M","owner_display_name":"O'Connor Rita M","owner_url":"/insider/0001389177","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2120.0,"shares_display":"2,120","price_per_share":3.8333,"price_display":"3.83","price_state":"stated","total_value":8126.596,"total_display":"8,126.60","total_whole":"8,127","shares_owned_after":12970.0,"shares_owned_after_display":"12,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-02","filed_date":"2020-09-03","scope":"insider"},{"id":2708902,"accession":"0001193805-20-001112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-20-001112","line_url":"/filing/0001193805-20-001112#line-1","is_derivative":false,"issuer_cik":"0001389177","issuer_name":"PLx Pharma Inc.","issuer_ticker":"PLXP","issuer_name_source":null,"issuer_url":"/issuer/0001389177","owner_cik":"0001389177","owner_name":"O'Connor Rita M","owner_display_name":"O'Connor Rita M","owner_url":"/insider/0001389177","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":3.7416,"price_display":"3.74","price_state":"stated","total_value":16837.2,"total_display":"16,837.20","total_whole":"16,837","shares_owned_after":10850.0,"shares_owned_after_display":"10,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-03","scope":"insider"},{"id":2249527,"accession":"0000921895-20-002310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-20-002310","line_url":"/filing/0000921895-20-002310#line-2","is_derivative":false,"issuer_cik":"0001389177","issuer_name":"PLx Pharma Inc.","issuer_ticker":"PLXP","issuer_name_source":null,"issuer_url":"/issuer/0001389177","owner_cik":"0001389177","owner_name":"O'Connor Rita M","owner_display_name":"O'Connor Rita M","owner_url":"/insider/0001389177","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4050.0,"shares_display":"4,050","price_per_share":3.973,"price_display":"3.97","price_state":"stated","total_value":16090.65,"total_display":"16,090.65","total_whole":"16,091","shares_owned_after":6350.0,"shares_owned_after_display":"6,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-21","filed_date":"2020-08-24","scope":"insider"},{"id":2249523,"accession":"0000921895-20-002310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-20-002310","line_url":"/filing/0000921895-20-002310#line-1","is_derivative":false,"issuer_cik":"0001389177","issuer_name":"PLx Pharma Inc.","issuer_ticker":"PLXP","issuer_name_source":null,"issuer_url":"/issuer/0001389177","owner_cik":"0001389177","owner_name":"O'Connor Rita M","owner_display_name":"O'Connor Rita M","owner_url":"/insider/0001389177","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300.0,"shares_display":"2,300","price_per_share":3.7677,"price_display":"3.77","price_state":"stated","total_value":8665.71,"total_display":"8,665.71","total_whole":"8,666","shares_owned_after":2300.0,"shares_owned_after_display":"2,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-20","filed_date":"2020-08-24","scope":"insider"},{"id":7836148,"accession":"0001209191-07-062734","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-062734","line_url":"/filing/0001209191-07-062734#line-2","is_derivative":false,"issuer_cik":"0001319439","issuer_name":"Adams Respiratory Therapeutics, Inc.","issuer_ticker":"ARXT","issuer_name_source":null,"issuer_url":"/issuer/0001319439","owner_cik":"0001389177","owner_name":"O'Connor Rita M","owner_display_name":"O'Connor Rita M","owner_url":"/insider/0001389177","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4212.0,"shares_display":"4,212","price_per_share":43.49,"price_display":"43.49","price_state":"stated","total_value":183179.88,"total_display":"183,179.88","total_whole":"183,180","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-08","filed_date":"2007-11-08","scope":"insider"},{"id":8238585,"accession":"0001209191-07-049931","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-049931","line_url":"/filing/0001209191-07-049931#line-2","is_derivative":false,"issuer_cik":"0001319439","issuer_name":"Adams Respiratory Therapeutics, Inc.","issuer_ticker":"ARXT","issuer_name_source":null,"issuer_url":"/issuer/0001319439","owner_cik":"0001389177","owner_name":"O'Connor Rita M","owner_display_name":"O'Connor Rita M","owner_url":"/insider/0001389177","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1653.0,"shares_display":"1,653","price_per_share":40.52,"price_display":"40.52","price_state":"stated","total_value":66979.56,"total_display":"66,979.56","total_whole":"66,980","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-20","filed_date":"2007-08-22","scope":"insider"},{"id":7131746,"accession":"0001209191-07-043796","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-043796","line_url":"/filing/0001209191-07-043796#line-2","is_derivative":false,"issuer_cik":"0001319439","issuer_name":"Adams Respiratory Therapeutics, Inc.","issuer_ticker":"ARXT","issuer_name_source":null,"issuer_url":"/issuer/0001319439","owner_cik":"0001389177","owner_name":"O'Connor Rita M","owner_display_name":"O'Connor Rita M","owner_url":"/insider/0001389177","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":96000.0,"total_display":"96,000.00","total_whole":"96,000","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-24","filed_date":"2007-07-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001497504","name":"PLx Pharma Inc.","url":"/issuer/0001497504","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2020-08-24","last_seen":"2022-03-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001319439","name":"Adams Respiratory Therapeutics, Inc.","url":"/issuer/0001319439","role":"Officer (CFO and Treasurer)","n_filings":3,"first_seen":"2007-07-25","last_seen":"2007-11-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001389177","retrieved_at":"2026-08-25T13:35:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}